PRESS RELEASE published on 08/28/2025 at 07:10, 1 year 1 month ago EDAG Engineering Group AG: Decline in revenues and EBIT due to ongoing market restraint in the first half of 2025, expansion of defence activities EDAG Engineering Group AG reports decline in revenues and EBIT for the first half of 2025 due to market restraint, focusing on defence activities for growth Revenues EBIT EDAG Engineering Group AG Defence Activities Market Restraint
PRESS RELEASE published on 08/28/2025 at 07:02, 1 year 1 month ago Press release: Leonteq expands market presence with leverage products on BX Swiss Leonteq expands market presence with leverage products on BX Swiss, launching over 5,000 products with leading execution quality and strategic growth plans Switzerland Leonteq BX Swiss Market Presence Leverage Products
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Germany Sandoz Antithrombotic Treatment Rivaroxaban Generic Medicine
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago SoftwareOne reports revenue decline and improved margin as expected in H1 2025; Crayon integration on track SoftwareOne Holding AG reports revenue decline and improved margin in H1 2025, including Crayon integration progress. Company outlook focuses on growth and synergy achievements Revenue Decline SoftwareOne Margin Improvement H1 2025 Crayon Integration
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Positive development across all major KPI: STRABAG on track for profitable growth STRABAG SE announces positive first half 2025 results with output up by 7% to €8.9 billion, order backlog at €28.4 billion (+13%), and EBIT increased by 58% to €129.4 million. Expansion into Australia contributing to growth Profitable Growth STRABAG SE EBIT Growth First Half 2025 Results Output Increase
REGULATED PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals Biophytis Sarcopenia Phase 3 EMA Belgian Regulatory Approval
PRESS RELEASE published on 08/28/2025 at 07:00, 1 year 1 month ago Exail strengthens its position in the surface drone sector with the first sale of a new long-range DriX drone model Exail Technologies announces the sale of the DriX H-9, expanding its autonomous surface drone solutions for civil and defense markets. The H-9 offers enhanced capabilities for maritime missions Exail Technologies Defense Applications Autonomous Drones DriX H-9 Maritime Missions
PRESS RELEASE published on 08/28/2025 at 06:59, 1 year 1 month ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
PRESS RELEASE published on 08/28/2025 at 06:57, 1 year 1 month ago EQS-Adhoc: PIERER Mobility AG: Results for the first half of 2025 PIERER Mobility AG announces successful completion of restructuring proceedings in H1 2025, with positive results and strategic initiatives for motorcycle and bicycle segments PIERER Mobility AG Results Motorcycle Restructuring Proceedings Bicycle
PRESS RELEASE published on 08/28/2025 at 06:50, 1 year 1 month ago Daldrup & Söhne AG increases EBIT margin and specifies EBIT forecast Daldrup & Söhne AG increases EBIT margin to 12.6% and revises 2025 EBIT forecast. Order backlog reaches EUR 140 million. Detailed 2025 outlook provided Financial Performance EBIT Margin Order Backlog Forecast Daldrup & Söhne
Published on 10/19/2026 at 23:20, 8 hours 28 minutes ago CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 23:00, 8 hours 48 minutes ago Eskay Mining Corp. Announces Results of Annual Meeting
Published on 10/19/2026 at 22:50, 8 hours 58 minutes ago Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 9 hours 47 minutes ago Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing
Published on 10/20/2026 at 07:35, 13 minutes ago Coway Sweeps the 2026 Good Design Award, Proving Unmatched Design Prowess Across Its Entire Portfolio
Published on 10/20/2026 at 07:30, 18 minutes ago REINET INVESTMENTS S.C.A. SHARE BUYBACK PROGRAMME – UPDATE 20 October 2026
Published on 10/20/2026 at 07:15, 33 minutes ago Blue Cap AG: Preliminary Figures for the first half of 2026
Published on 10/20/2026 at 07:00, 48 minutes ago INFICON to Publish its Third Quarter 2026 Results on Tuesday, October 27, 2026
Published on 10/20/2026 at 07:00, 48 minutes ago BioVersys announces publication of BV100 lung penetration and drug interaction data in two leading peer-reviewed antimicrobial journals
Published on 10/20/2026 at 07:45, 3 minutes ago Schneider Electric announces the success of its €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.
Published on 10/19/2026 at 18:40, 13 hours 8 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:00, 13 hours 48 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 17:45, 14 hours 3 minutes ago Declaration of transactions on own shares from October 12, 2026 to October 18, 2026